Clinical evaluation of urinary nuclear matrix protein 22 as a marker for bladder cancer
The purpose of this study is to evaluate the clinical usefulness of urinary nuclear matrix protein 22 (NMP22) as a marker for bladder cancer. We examined the positive rates of NMP22 test, urinary cytology and bladder tumor antigen (BTA) test, and compared the positive rate of NMP22 test with that in...
| Publié dans: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 47(2001), 4 vom: 24. Apr., Seite 247-50 |
|---|---|
| Auteur principal: | |
| Autres auteurs: | , , |
| Format: | Article |
| Langue: | Japanese |
| Publié: |
2001
|
| Accès à la collection: | Hinyokika kiyo. Acta urologica Japonica |
| Sujets: | English Abstract Journal Article Biomarkers, Tumor Nuclear Proteins nuclear matrix protein 22 |